---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-018920"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2022-09-28T23:59:59+00:00"
generated_at: "2026-06-23T06:58:44.930684+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Treace Medical appoints Lance Berry and Jane Kiernan to board effective Oct 1, 2022

## Summary
- Appointed Lance A. Berry (former Wright Medical CFO) and Jane E. Kiernan (CEO of Surgimatix) to board, effective Oct 1, 2022.
- Berry will serve on Audit Committee; Kiernan on Compensation Committee.
- Both qualify as independent directors under Nasdaq rules.
- Berry brings ~20 years of medical device financial leadership; Kiernan has 30+ years of healthcare executive experience.

## SEC filing metadata
- accession: 0000950170-22-018920
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2022-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/0000950170-22-018920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/tmci-20220927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-018920
- JSON: https://secwatch.observer/filing/0000950170-22-018920.json
- Plain text: https://secwatch.observer/filing/0000950170-22-018920.txt

## Key facts
- Executive change
  Jane E. Kiernan was appointed as Director at TREACE MEDICAL CONCEPTS, INC..
  - Action: appointed
  - Role: Director
  source text: On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/0000950170-22-018920-index.htm
- Executive change
  Lance A. Berry was appointed as Director at TREACE MEDICAL CONCEPTS, INC..
  - Action: appointed
  - Role: Director
  source text: On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017022018920/0000950170-22-018920-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.